Syllabus - University of West Alabama



Date: 9-3-04 Instuctor: Brad Montgomery

E-mail bsm@uwa.edu Phone No.: (205)652-3696 Office No: 220

Athletic Training

AH 300

Medical Aspects of Sports

TEXT: Arnheim, Daniel D. & Prentice, William E. Principles of Athletic Training. Madison, WI.,

Brown & Benchmark, 11th Edition, 2003.

CREDIT HOURS: 3 semester hours

PREREQUISITE: AH 200, BY 231, & BY 234

DESCRIPTION: General medical problems, pharmacology, and psychology in Sports Medicine

OBJECTIVES: At the conclusion of this course, the successful student will be able to:

1. Understand how to work with the team physician and other medical personnel in evaluating & treating the various general medical problems of the athlete.

1. Understand how to provide health care information, advisement and counseling to athletes, parents, and coaches on matters pertaining to the physical, psychological, and emotional health and well being of the competitive athlete.

2. Understand the control of the spread of infectious viruses and other blood borne pathogens.

3. Prevent the role of the OSHA guidelines in the prevention of disease transmission.

4. Understand medical aspects of health conditions related to sport; such as: shock, heart conditions, menstrual irregularities, and eating disorders.

5. Understand health conditions related to sport; such as: viral, bacterial, fungal and environmental disease

6. Understand the psychological aspect of an athlete’s reaction to injury, pathology, or trauma.

7. Understand the recognition, treatment, and referral of various skin disorders found in athletics.

8. Understand the use and/or abuse of drugs in Sports and Sports Therapy

CONTENT OUTLINE:

A. Blood Borne Pathogens (AIDS & HBV) Chapter 14

B. OSHA regulations Chapter 14

C. Heart Conditions Chapter 26

D. Eating Disorders Chapter 5

TEST 1

A. Skin disorders Chapter 28

A. Drug use and Abuse in Sports Chapter 17

TEST 2

E. Gynecological & Urological Irregularities Chapter 29

F. Eye and Ear Injury and disease Chapter 27

G. Anaphylaxis and Asthma Conditions Chapter 29

H. Upper Respiratory, Endocrine, GI Tract, & STD’S Chapter 29

TEST 3

COURSE REQUIREMENTS:

A. The student will attend at least 2/3 of all class meetings as stated on page 52 of the 1997-8 UWA General Catalog.

A. The student will participate fully in all practical laboratory sessions

A. Supplemental readings

A. One pharmaceutical project/paper

A. One general medical condition or skin disorders project/paper

A. Unannounced pop tests may be given at any time

A. Three major objective examinations

A. One comprehensive final examination

B. Attend guest lecture by local pharmacist

EVALUATION:

A. Supplemental reading 50 pts. - 10 pts. Each 07% of total grade

A. Two paper/projects 200 pts. 100 pts. Each 27% of total grade

A. Three major, objective examinations 300 pts. 100/test 39% of total grade

A. One comprehensive final examination 150 pts. 20% of total grade

GRADING: Total 700 pts.

626-700 pts. =A

556-625 pts. =B

486-555 pts. =C

416-485 pts. =D

below 416 =F

POLICIES:

A. Attendance: A student cannot receive credit for a course if he/she does not attend at least two-thirds of the class meetings, regardless of the reason for the absence.

B. Academic Misconduct: The academic misconduct policy of The University of West Alabama will be followed in this course as it is stated in the university catalogue.

C. Requests for Accommodation: All requests for accommodation, for this course or any school event, are welcome, from the student or his parent.

D. Discussion of Grades with the Professor: Any student who receives a failing grade during this course is urged to discuss this with the instructor soon after the grades have been returned to the students.

NATA-BOC COMPENTENCIES NECESSARY TO PASS THIS COURSE:

These competencies will be covered in whole or in part as determined by the material.

RISK MANAGEMENT AND INJURY PREVENTION

Cognitive Domain

2 - Appraises the risk factors associated with common congenital and acquired abnormalities, disabilities, and diseases.

16 - Identifies the precautions and risks associated with exercise in individuals who have systemic medical conditions.

17 - Describes the components of an educational program for self-identification of the warning signs of cancer, including self-examination of the breasts and testicles.

PATHOLOGY OF INJURIES AND ILLNESSES

Cognitive Domain

13 - Outlines the autoimmune and immunodeficiency responses and their associated diseases (e.g., lupus, HIV/AIDS).

18 - Describes the signs and symptoms of deep and superficial vein thromboses, pulmonary embolism and other emboli, and myocardial infraction.

Affective Domain

2 - Recognizes that physician consultation is a moral and ethical necessity in the diagnosis and treatment of pathologic conditions.

ASSESSMENT AND EVALUATION

Cognitive Domain

1 - Demonstrates knowledge of the normal anatomical structures of the human body systems and their physiological functions, including the musculoskeletal (including articulations), nervous (central and peripheral), cardiovascular, respiratory, digestive, urogenital, endocrine, dermatological, reproductive, and special sensory systems.

Affective Domain

6 - Accepts the professional, ethical, and legal parameters that define the proper role of the certified athletic trainer in the evaluation and appropriate medical referral of injuries and illnesses of athletes and others involved in physical activity.

ACUTE CARE OF INJURIES AND ILLNESSES

Cognitive Domain

1 - Explains the legal, moral, and ethical parameters that define the scope of first aid and emergency care, and identifies the proper roles and responsibilities of the certified athletic trainer.

2 - Describes the availability, contents, purposes, and maintenance of contemporary first aid and emergency care equipment.

3 - Determines what emergency care supplies and equipment are necessary for event coverage, such as biohazardous waste disposal containers, splints, short-distance transportation equipment, emergency access tools, primary survey instruments (CPR mask, bag-valve-mask), and ice.

4 - Interprets standard nomenclature of athletic injuries and illnesses.

10 - Applies the current standards of first aid, emergency care, rescue breathing, and cardiopulmonary resuscitation for the professional rescuer, including (1) use of a bag-valve-mask, (2) use of a pocket mask, and (3) the chin lift-jaw thrust maneuver.

14 - Describes the management of external hemorrhage, including the location of pressure points, use of universal precautions, and proper disposal of biohazardous materials.

16 - Recommends the appropriate use of aseptic or sterile techniques, approved sanitation methods, and universal precautions for the cleansing and dressing of wounds.

32 - Recognizes the signs and symptoms of shock.

33 - Identifies the different types of shock type (traumatic, hypovolemic, anaphylactic, septic) and the proper management of each.

34 - Differentiates the signs and symptoms of diabetic coma and insulin shock.

35 - Describes the proper treatments of diabetic coma and insulin shock.

37 - Recognizes the signs and symptoms of toxic drug overdose.

38 - Describes the signs, symptoms, and causes of allergic, thermal, and chemical reactions of the skin.

39 - Recognizes the differences between infestations, insect bites, and other skin conditions.

40 - Recognizes the signs and symptoms of common infectious diseases, and takes appropriate steps to prevent disease transmission through appropriate medical referral (see General Medical Clinical Proficiencies, 61-64, for a list of common infectious diseases). {~X-REF}

42 - Uses the information obtained during the examination to determine when to refer an injury or illness for further or immediate medical attention d (e.g., a life- or limb-threatening situation).

Affective Domain

4 - Appreciates the role and function of various medical/paramedical specialties, and values their respective areas of expertise in the definitive treatment of acute injuries and illnesses.

7 - Realizes the importance of identifying signs and symptoms in cases of possible shock, internal bleeding, and closed-head trauma.

15 - Accepts the approved aseptic and sterile methods for cleaning, treating, and bandaging wounds and for disposing of biohazardous waste.

PHARMACOLOGY

Cognitive Domain

1 - Recognizes the general concepts and differences in the legal regulation of non-prescription, prescription, and classified pharmaceuticals.

2 - Recalls and can access the laws, regulations, and procedures that govern storage, transportation, dispensation, and recording prescription and nonprescription medications (Controlled Substance Act, scheduled drug classification, and state statutes).

3 - Identifies the role of the Food and Drug Administration (FDA) in approving and recalling drugs.

4 - Identifies appropriate terminology and pharmaceutical abbreviations used in the prescription and dispensation of medications.

5 - Identifies the common resources used to identify indications, contraindications, precautions, and adverse reactions for prescription and nonprescription medications.

6 - Recalls how the concept of potency and expiration affects drug dose protocols.

7 - Identifies common methods used to administer medication.

8 - Relates the relationship of generic to brand name pharmaceuticals.

9 - Describes the kinetic process of absorption, distribution, metabolism, and elimination of administered medication.

10 - Describes how physical activity may influence a drug's therapeutic effect.

13 - Recognizes that adverse drug reactions can be immediate (acute) or delayed (chronic).

14 - Describes the potential risks of co-interaction between two or more pharmaceutical agents.

15 - Recognizes the difference between cortical and anabolic steroids and other androgenics.

16 - Describes the general indications, contraindications, and adverse reactions of prescription and nonprescription anti-inflammatory and antiarthritic medications (e.g., steroidal and nonsteroidal).

17 - Lists the general indications, contraindications, and adverse reactions of commonly used prescription and nonprescription analgesic medications.

18 - Lists the general indications, contraindications, and adverse reactions of prescription and nonprescription local anesthetics.

19 - Lists the general indications, contraindications, and adverse reactions of bronchodilators and other prescription and nonprescription respiratory medications as they relate to physical activity.

20 - Identifies the general indications, contraindications, and adverse reactions of prescription and nonprescription antibiotics.

22 - Identifies the general adverse reactions of gastrointestinal prescription and nonprescription medications.

24 - Recalls the general indications, contraindications, and adverse reactions of prescription and nonprescription topical applications.

25 - Identifies the usage patterns, general effects, and adverse short- and long-term reactions of performance enhancing drugs.

Psychomotor Domain

1 - Employs the Physician's Desk Reference (PDR), the Drug Facts and Comparisons, or on-line services to obtain information on the medications prescribed for athletes and others involved in physical activity.

2 - Follows federal, state, and local regulations regarding storing, transporting, dispensing, and recording medications.

3 - Documents tracking of medications by name, manufacturer, amount, dosage, lot number, and expiration date.

7 - Replicates procedures for using an asthmatic inhaler to prevent and treat exercise-induced bronchial spasms and/or asthmatic conditions.

Affective Domain

1 - Recognizes that pharmacology applies to the immediate and ongoing care of injury and illness.

2 - Recognizes the importance of pharmacological concepts in health care.

3 - Accepts physician (or other qualified health care provider) and pharmacist consultation as a legal, moral, and ethical necessity in the prescription and dispensation of medication.

4 - Appreciates the use of clinical references such as the PDR and clinical databases to identify medications.

6 - Supports the moral and ethical behavior of athletic trainers in dealing with the issues of drug use and abuse in sports.

7 - Accepts moral and ethical responsibility for maintaining current knowledge of the medications commonly prescribed to athletes and others involved in physical activity.

8 - Advocates moral and ethical behavior of self and colleagues in dealing with issues of a pharmacological nature.

9 - Promotes accountability for moral and ethical decision-making in pharmacological issues.

THERAPEUTIC MODALITIES

Cognitive Domain

5 - Describes the role and function of the common prescription and nonprescription pharmacological agents that are used in conjunction with therapeutic modalities (e.g., topical ointments, phonophoresis, iontophoresis.

GENERAL MEDICAL CONDITIONS AND DISABILITIES

Cognitive Domain

1 - Describes congenital or acquired abnormalities, physical disabilities, and diseases.

2 - Identifies common illnesses and diseases of the body's systems based on contemporary epidemiological studies of the injuries of athletes and others involved in physical activity.

3 - Describes the general principles of health maintenance and personal hygiene, including skin care, dental hygiene, sanitation, immunizations, avoidance of infectious and contagious diseases, diet, rest, exercise, and weight control.

4 - Recognizes common eye pathologies (e.g., conjunctivitis, hyphema, corneal injury, and scleral trauma).

5 - Recognizes common ear pathologies (e.g., otitis, ruptured tympanic membrane, and impacted cerumen).

6 - Recognizes common pathologies of the mouth, sinus, oropharynx, and nasopharynx.

7 - Lists the common causes, signs, and symptoms of respiratory infections (e.g., pneumonia, bronchitis, sinusitis, URI, and asthma).

9 - Describes strategies for reducing the frequency and severity of asthma attacks.

10 - Compares and contrasts the signs and symptoms of respiratory tract conditions (e.g., common cold, influenza, allergic rhinitis, sinusitis, bronchitis, asthma, pneumonia, and pleurisy).

11 - Identifies the possible causes of sudden death syndrome among athletes and others involved in physical activity.

14 - Explains the typical history, signs, and symptoms associated with cardiopulmonary conditions.

15 - Describes common heart conditions, such as coronary artery disease, hypertrophic cardiomyopathy, heart murmurs, and mitral valve prolapse.

16 - Identifies the typical symptoms and clinical signs of an injury or illness, including those associated with local tissue inflammation (cellulitis) and systemic infection (lymphangitis, lymphadenitis, bacteremia).

17 - Describes the common conditions that affect the liver, gall bladder, and pancreas (e.g., jaundice, hepatitis, diabetes mellitus, and pancreatitis).

18 - Explains and recognizes the etiology, signs, symptoms, and management of diabetes mellitus.

19 - Describes the signs and symptoms of the common disorders of the gastrointestinal tract.

20 - Lists examples of the common conditions of the urinary tract, kidneys, and bladder (e.g., urinary tract infection (UTI) and kidney stones).

21 - Lists the common infections and conditions of the male reproductive organs (e.g., epididymitis, varicocele, hydrocele, undescended testicle, and testicular cancer).

23 - Describes the common conditions of the breast (e.g., gynecomastia, cancer, and fibrous cysts).

24 - Describes the various menstrual irregularities, the relationship that physical activity plays in their development, their resolutions, and their implications on performance, as well as detrimental systemic effects (e.g., oligomenorrhea, amenorrhea, and dysmenorrhea).

26 - Describes the signs, symptoms, and management of common sexually transmitted diseases (STD).

27 - Recognizes skin lesions (e.g., wounds and thermal, electrical, and radiation injury), infections (e.g., bacterial, fungal, and viral), and disorders (e.g., bites, acne, dermatitis, folliculitis, and eczema); ;.

28 - Identifies skin infections that are potentially contagious (e.g., impetigo, staph infection).

34 - Identifies the common signs and symptoms of contagious viral diseases.

35 - Lists the advantages and disadvantages of sports participation by individuals with hepatitis B virus or human immunodeficiency virus (HIV).

36 - Describes the etiology, signs, symptoms, and management of common viruses (e.g., human papillomavirus, Epstein-Barr virus, and hepatitis B virus).

37 - Describes where and how to seek appropriate medical assistance on disease control, notification, and epidemic prevention.

Psychomotor Domain

4 - Recognizes and manages the common disorders of the gastrointestinal tract.

5 - Recognizes and applies the appropriate treatments for diabetic coma and insulin shock.

6 - Acts quickly to contain skin infections that are potentially contagious, and refers the patient when appropriate.

8 - Recognizes and takes the appropriate steps to manage and control common contagious viral and infectious diseases.

16 - Refers an individual who presents with complaints, signs, and/or symptoms of genitourinary or reproductive disorders to a physician.

Affective Domain

1 - Supports the moral and ethical behavior of athletic trainers in issues dealing with diseases of athletics and physical activity.

2 - Recognizes the moral and ethical responsibility of taking situational control in the containment of common contagious viral and infectious diseases.

3 - Accepts the roles of medical and allied health personnel in the referral, management, and treatment of athletes and others involved in physical activity suffering from general medical conditions.

NUTRITIONAL ASPECTS

Cognitive Domain

1 - Describes personal health habits (hygiene, diet, nutrition, weight control, proper amount of sleep, effects of alcohol, tobacco, and drugs) and their role in preventing injury or illness and in maintaining a healthy lifestyle.

7 - Describes the common illnesses and injuries that are attributed to poor nutrition.

9 - Delineates the effects of poor dietary habits on bone loss, injury, and long term health.

10 - Applies the principles of nutrition, including the roles of fluids and electrolytes, vitamins, minerals, ergogenic aids, macronutrients, carbohydrates, protein, fat, and dietary supplements, as they relate to the dietary and nutritional needs of athletes and others involved in physical activity.

12 - Paraphrases the prevailing misconceptions regarding the proper use of food, fluids, and nutritional supplements (common food fads and fallacies and strength or weight gain diets).

13 - Describes the advantages or disadvantages of supplementing nutrients in the athlete's diet.

14 - Describes the principles, advantages, and disadvantages of the ergogenic aids and dietary supplements used by athletes and others involved in physical activity, in an effort to improve performance.

15 - Recognizes the implications of FDA endorsement of nutritional products.

23 - Describes the signs, symptoms, and physical consequences of disordered eating.

24 - Explains the referral system for individuals with disordered eating.

Affective Domain

3 - Appreciates the long-term effects of disordered eating, bone density loss, and secondary amenorrhea on the skeletal health of the physically active.

4 - Recognizes the need for and implements proper referral for eating disorders.

PSYCHOSOCIAL INTERVENTION AND REFERRAL

Cognitive Domain

1 - Describes the current psychosocial and sociocultural issues and problems confronting athletic training and sports medicine and identifies their effects on athletes and others involved in physical activity.

6 - Disseminates information regarding the roles and functions of various community-based health care providers (sport psychologists, counselors, social workers).

7 - Describes the accepted protocols that govern the referral of athletes and other physically active individuals to psychological, community health, or social services.

11 - Identifies the symptoms and clinical signs of common disordered eating (anorexia nervosa, bulimia) and the psychological and sociocultural factors associated with these disorders.

13 - Identifies the medical and community-based resources that disseminate information regarding safe sexual activity and the health risk factors associated with sexually transmitted diseases.

14 - Describes commonly abused substances (e.g., alcohol, tobacco, stimulants, nutritional supplements, steroids, marijuana, and narcotics) and their impact on an individual's health and physical performance.

15 - Recognizes the signs and symptoms of drug abuse and the use of ergogenic aids and other substances.

16 - Identifies the societal influences toward substance abuse in the athletic and physically active population.

17 - Contrasts psychological and physical dependence, tolerance, and withdrawal syndromes that may be seen in individuals addicted to alcohol, prescription or nonprescription medications, and/or 'street' drugs.

19 - Identifies contemporary personal, school, and community health service agencies, such as community-based psychological and social support services.

20 - Formulates a plan for appropriate psychological intervention and referral with all involved parties when confronted with a catastrophic event.

21 - Describes the acceptance and grieving processes that follow a catastrophic event.

24 - Cites the potential need for psychosocial intervention and referral when dealing with populations requiring special consideration (e.g., those with exercise-induced asthma, diabetes, seizure disorders, drug allergies and interactions, or unilateral organs).

Psychomotor Domain

1 - Intervenes, when appropriate, with an individual with a suspected substance abuse problem.

Affective Domain

5 - Accepts the moral and ethical responsibility to intervene in situations of suspected or known use and/or abuse of legal and illegal drugs and chemicals.

HEALTH CARE ADMINISTRATION

Cognitive Domain

7 - Describes the universal precautions mandated by the Occupational Safety and Health Administration (OSHA), and discusses how they apply to the athletic trainer.

14 - Uses accepted medical terminology and abbreviations (SOAP, CPT and HCFA coding).

29 - Describes federal and state infection control regulations and guidelines as they pertain to the prevention, exposure, and control of infectious disease.

35 - Describes the role and function of various community-based medical, paramedical, and other health care providers.

37 - Explains the protocol that governs the referral of patients to medical or paramedical specialists and other health care providers.

39 - Locates and interprets current banned-drug lists that are published by various governing athletic associations (National Collegiate Athletic Association [NCAA], United States Olympic Committee [USOC], International Olympic Committee [IOC], etc).

45 - Identifies the roles and responsibilities of allied health care personnel in providing services to athletes and others involved in physical activity.

Affective Domain

1 - Appreciates the roles and responsibilities of medical and allied health care providers, and respects the systems that each provider works within.

2 - Appreciates the roles and functions of various medical and paramedical specialties as well as their respective areas of expertise in the acute care of injuries and illnesses to athletes and others involved in physical activity.

PROFESSIONAL DEVELOPMENT AND RESPONSIBILITIES

Affective Domain

9 - Respects the role and responsibilities of the other health care professions.

(C) 1999, National Athletic Trainers' Association. All rights reserved.

Proficiencies

|T.O. |Subj |# |Outcome |Taught |Covered |Eval. |

| |area | | | | | |

| |GM |7-1-9-1I |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH200, AH300 |AH300 |

| | | |conditions: frostbite | | | |

| |GM |7-1-9-4E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH200, AH300 |AH300 |

| | | |conditions of the Cardiovascular System: shock | | | |

| |PH |4-1-2A |Document, or simulate the documentation of, the tracking of medications by recording the following|AH101 |AH200, AH300 |AH382 |

| | | |information about the medication: name | | | |

| |PH |4-1-2B |Document, or simulate the documentation of, the tracking of medications by recording the following|AH101 |AH200, AH300 |AH382 |

| | | |information about the medication: manufacturer | | | |

| |PH |4-1-2C |Document, or simulate the documentation of, the tracking of medications by recording the following|AH101 |AH200, AH300 |AH382 |

| | | |information about the medication: amount | | | |

| |PH |4-1-2D |Document, or simulate the documentation of, the tracking of medications by recording the following|AH101 |AH200, AH300 |AH382 |

| | | |information about the medication: dosage | | | |

| |PH |4-1-2E |Document, or simulate the documentation of, the tracking of medications by recording the following|AH101 |AH200, AH300 |AH382 |

| | | |information about the medication: lot number | | | |

| |PH |4-1-2F |Document, or simulate the documentation of, the tracking of medications by recording the following|AH101 |AH200, AH300 |AH382 |

| | | |information about the medication: expiration date | | | |

| |GM |7-1-9-12D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH300 |

| | | |conditions - Neurological Disorders: meningitis | | | |

| |GM |7-1-9-1A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: abscesses | | | |

| |GM |7-1-9-1B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: acne vulgaris | | | |

| |GM |7-1-9-1C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: carbuncle | | | |

| |GM |7-1-9-1D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: cellulitis | | | |

| |GM |7-1-9-1E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: molluscum contagiosum | | | |

| |GM |7-1-9-1F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: dermatitis | | | |

| |GM |7-1-9-1G |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: eczema | | | |

| |GM |7-1-9-1H |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: folliculitis | | | |

| |GM |7-1-9-1J |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: furunculosis | | | |

| |GM |7-1-9-1K |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: herpes simplex | | | |

| |GM |7-1-9-1L |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: tinea versicolor | | | |

| |GM |7-1-9-1N |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: pediculosis | | | |

| |GM |7-1-9-1O |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: herpes zoster | | | |

| |GM |7-1-9-1P |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: hives | | | |

| |GM |7-1-9-1Q |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: impetigo | | | |

| |GM |7-1-9-1R |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: psoriasis | | | |

| |GM |7-1-9-1S |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: ringworm | | | |

| |GM |7-1-9-1T |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: scabies | | | |

| |GM |7-1-9-1U |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: sebaceous cysts | | | |

| |GM |7-1-9-1V |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: tinea cruris | | | |

| |GM |7-1-9-1W |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: tinea pedis | | | |

| |GM |7-1-9-1X |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: verruca plantaris | | | |

| |GM |7-1-9-1Y |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: verruca vulgaris | | | |

| |GM |7-1-9-1Z |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: tinea capitis | | | |

| |GM |7-1-9-13A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions - Systemic Diseases: iron-deficiency anemia | | | |

| |GM |7-1-9-13B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions - Systemic Diseases: sickle cell anemia | | | |

| |GM |7-1-9-13C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions - Systemic Diseases: Lyme disease | | | |

| |GM |7-1-9-9A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: kidney stones | | | |

| |GM |7-1-9-9B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: spermatic cord torsion | | | |

| |GM |7-1-9-9C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: candidiasis | | | |

| |GM |7-1-9-9D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: urethritis | | | |

| |GM |7-1-9-9E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: urinary tract infection | | | |

| |GM |7-1-9-9F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: hydrocele | | | |

| |GM |7-1-9-9G |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: varicocele | | | |

| |GM |7-1-9-4A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: hypertension | | | |

| |GM |7-1-9-4B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: hypertrophic myocardiopathy | | | |

| |GM |7-1-9-4C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: hypotension | | | |

| |GM |7-1-9-4D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: migraine headache | | | |

| |GM |7-1-9-4F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: syncope | | | |

| |GM |7-1-9-7B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions associated with Eating Disorders: bulimia | | | |

| |GM |7-1-9-10A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: amenorrhea | | | |

| |GM |7-1-9-10B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: dysmenorrheal | | | |

| |GM |7-1-9-10C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: oligomenorrhea | | | |

| |GM |7-1-9-10D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: pelvic inflammatory disease | | | |

| |GM |7-1-9-10E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: vaginitis | | | |

| |GM |7-1-9-11A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Viral Syndromes: infectious mononucleosis | | | |

| |GM |7-1-9-11B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Viral Syndromes: measles | | | |

| |GM |7-1-9-11C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Viral Syndromes: mumps | | | |

| |GM |7-1-9-8B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: hepatitis | | | |

| |GM |7-1-9-8C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: chlamydia | | | |

| |GM |7-1-9-8D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: genital warts | | | |

| |GM |7-1-9-8E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: gonorrhea | | | |

| |GM |7-1-9-8F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: syphilis | | | |

| |NA |8-1-1B |demonstrate the ability to access & recommend nutritional guidelines for weight loss |PE251 |AH300 |AH300 |

| |NA |8-1-1C |demonstrate the ability to access & recommend nutritional guidelines for weight gain |PE251 |AH300 |AH300 |

| |NA |8-1-1A |demonstrate the ability to access & recommend nutritional guidelines for pre-participation meals |AH200 |AH300 |AH382 |

| |NA |8-1-1D |demonstrate the ability to access & recommend nutritional guidelines for fluid replacement |AH200 |AH300 |AH382 |

| |NA |8-1-2 |demonstrate the ability to use the nutritional food pyramid |AH200 |AH300 |AH481 |

| |NA |8-1-3A |demonstrate the ability to access & assess the following nutritional intake values: RDA or |AH200 |AH300 |AH481 |

| | | |equivalency | | | |

| |NA |8-1-3B |demonstrate the ability to access & assess the following nutritional intake values: protein intake|AH200 |AH300 |AH481 |

| |NA |8-1-3C |demonstrate the ability to access & assess the following nutritional intake values: fat intake |AH200 |AH300 |AH481 |

| |NA |8-1-3D |demonstrate the ability to access & assess the following nutritional intake values: carbohydrate |AH200 |AH300 |AH481 |

| | | |intake | | | |

| |NA |8-1-3E |demonstrate the ability to access & assess the following nutritional intake values: vitamin intake|AH200 |AH300 |AH481 |

| |NA |8-1-3F |demonstrate the ability to access & assess the following nutritional intake values: mineral intake|AH200 |AH300 |AH481 |

| |NA |8-1-3G |demonstrate the ability to access & assess the following nutritional intake values: fluid intake |AH200 |AH300 |AH481 |

| |NA |8-1-7 |Identify proper referral sources for disordered eating |AH200 |AH300 |AH481 |

| |AC |3-2-1D |demonstrate the ability to apply superficial skin closures |AH102 |AH300 |AH482 |

| |PH |4-1-1A |Use the PDR or another drug reference to search for information on the medications commonly |AH200 |AH300 |AH482 |

| | | |prescribed to athletes & others involved in physical activity & to identify the following facts: | | | |

| | | |generic & brand names | | | |

| |PH |4-1-1B |Use the PDR or another drug reference to search for information on the medications commonly |AH200 |AH300 |AH482 |

| | | |prescribed to athletes & others involved in physical activity & to identify the following facts: | | | |

| | | |indications for use | | | |

| |PH |4-1-1C |Use the PDR or another drug reference to search for information on the medications commonly |AH200 |AH300 |AH482 |

| | | |prescribed to athletes & others involved in physical activity & to identify the following facts: | | | |

| | | |contraindications | | | |

| |PH |4-1-1D |Use the PDR or another drug reference to search for information on the medications commonly |AH200 |AH300 |AH482 |

| | | |prescribed to athletes & others involved in physical activity & to identify the following facts: | | | |

| | | |warnings | | | |

| |PH |4-1-1E |Use the PDR or another drug reference to search for information on the medications commonly |AH200 |AH300 |AH482 |

| | | |prescribed to athletes & others involved in physical activity & to identify the following facts: | | | |

| | | |dosing | | | |

| |PH |4-1-1F |Use the PDR or another drug reference to search for information on the medications commonly |AH200 |AH300 |AH482 |

| | | |prescribed to athletes & others involved in physical activity & to identify the following facts: | | | |

| | | |other notes (e.g., banned substance) | | | |

| |PH |4-1-1G |Use the PDR or another drug reference to search for information on the medications commonly |AH200 |AH300 |AH482 |

| | | |prescribed to athletes & others involved in physical activity & to identify the following facts: | | | |

| | | |side (adverse) effects | | | |

| |PH |4-3-1A |Replicate the following procedures for using an emergency epinephrine injection to prevent |AH281 |AH300 |AH482 |

| | | |anaphylaxis: identify indications for an epinephrine injection | | | |

| |PH |4-3-1B |Replicate the following procedures for using an emergency epinephrine injection to prevent |AH281 |AH300 |AH482 |

| | | |anaphylaxis: demonstrate proper use through verbal & nonverbal instruction | | | |

| |PH |4-3-1C |Replicate the following procedures for using an emergency epinephrine injection to prevent |AH281 |AH300 |AH482 |

| | | |anaphylaxis: identify S & S that might indicate an allergic reaction to or overdose of epinephrine| | | |

| |PH |4-3-1D |Replicate the following procedures for using an emergency epinephrine injection to prevent |AH281 |AH300 |AH482 |

| | | |anaphylaxis: demonstrate proper storage of epinephrine injectable | | | |

| |PH |4-3-1E |Replicate the following procedures for using an emergency epinephrine injection to prevent |AH281 |AH300 |AH482 |

| | | |anaphylaxis: demonstrate proper disposal of used injection system | | | |

| |GM |7-1-9-2A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Eyes, Ears, Nose, & Throat: common cold | | | |

| |GM |7-1-9-2B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Eyes, Ears, Nose, & Throat: conjunctivitis | | | |

| |GM |7-1-9-2C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Eyes, Ears, Nose, & Throat: laryngitis | | | |

| |GM |7-1-9-2D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Eyes, Ears, Nose, & Throat: pharyngitis | | | |

| |GM |7-1-9-2E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Eyes, Ears, Nose, & Throat: rhinitis | | | |

| |GM |7-1-9-2F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Eyes, Ears, Nose, & Throat: sinusitis | | | |

| |GM |7-1-9-2G |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Eyes, Ears, Nose, & Throat: tetanus | | | |

| |GM |7-1-9-2H |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Eyes, Ears, Nose, & Throat: tonsillitis | | | |

| |GM |7-1-9-6A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: appendicitis | | | |

| |GM |7-1-9-6B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: colitis | | | |

| |GM |7-1-9-6C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: constipation | | | |

| |GM |7-1-9-6D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: diarrhea | | | |

| |GM |7-1-9-6E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: esophageal reflux | | | |

| |GM |7-1-9-6F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: gastritis | | | |

| |GM |7-1-9-6G |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: gastroenteritis | | | |

| |GM |7-1-9-6H |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: indigestion | | | |

| |GM |7-1-9-6I |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: ulcer | | | |

| |GM |7-1-9-6J |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH482 |

| | | |conditions of the Gastrointestinal Tract: irritable bowel syndrome | | | |

| |PH |4-1-3A |Locate the policies-&-procedures manual, identify the section on medications, & replicate the |AH101 |AH300, AH350 |AH482 |

| | | |procedures for administering medications to athletes & others involved in physical activity, which| | | |

| | | |include the following: determine type of over-the-counter (OTC) medication to be used according to| | | |

| | | |the physical ailment & established protocols | | | |

| |PH |4-1-3B |Locate the policies-&-procedures manual, identify the section on medications, & replicate the |AH101 |AH300, AH350 |AH482 |

| | | |procedures for administering medications to athletes & others involved in physical activity, which| | | |

| | | |include the following: identify the precautions, expiration date, lot number, & dosage for the | | | |

| | | |medication as provided on the package & individual dose packets | | | |

| |PH |4-1-3C |Locate the policies-&-procedures manual, identify the section on medications, & replicate the |AH101 |AH300, AH350 |AH482 |

| | | |procedures for administering medications to athletes & others involved in physical activity, which| | | |

| | | |include the following: administer OTC medication by providing verbal & written instruction for its| | | |

| | | |use to the patient & then recording & documenting the administration | | | |

| |GM |7-1-9-5A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300, PE250 |AH300 |

| | | |conditions of the Endocrine System: diabetes | | | |

| |GM |7-1-9-5B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300, PE250 |AH300 |

| | | |conditions of the Endocrine System: hyperthyroidism | | | |

| |GM |7-1-9-5C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300, PE250 |AH300 |

| | | |conditions of the Endocrine System: hypothyroidism | | | |

| |GM |7-1-9-5D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300, PE250 |AH300 |

| | | |conditions of the Endocrine System: pancreatitis | | | |

| |GM |7-1-9-3A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH281 |AH300, PE250 |AH482 |

| | | |conditions of the Respiratory System: asthma | | | |

| |GM |7-1-9-3B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH281 |AH300, PE250 |AH482 |

| | | |conditions of the Respiratory System: bronchitis | | | |

| |GM |7-1-9-3C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH281 |AH300, PE250 |AH482 |

| | | |conditions of the Respiratory System: hyperventilation | | | |

| |GM |7-1-9-3D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH281 |AH300, PE250 |AH482 |

| | | |conditions of the Respiratory System: hay fever | | | |

| |GM |7-1-9-3E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH281 |AH300, PE250 |AH482 |

| | | |conditions of the Respiratory System: influenza | | | |

| |GM |7-1-9-3F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH281 |AH300, PE250 |AH482 |

| | | |conditions of the Respiratory System: pneumonia | | | |

| |GM |7-1-9-3G |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH281 |AH300, PE250 |AH482 |

| | | |conditions of the Respiratory System: upper respiratory infection (URI) | | | |

| |GM |7-1-9-12A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300, PE251 |AH300 |

| | | |conditions - Neurological Disorders: epilepsy | | | |

| |GM |7-1-9-12B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300, PE251 |AH300 |

| | | |conditions - Neurological Disorders: syncope | | | |

| |GM |7-1-9-7A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300, PE251 |AH300 |

| | | |conditions associated with Eating Disorders: anorexia | | | |

| |GM |7-1-9-7C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300, PE251 |AH300 |

| | | |conditions associated with Eating Disorders: obesity | | | |

| |GM |7-1-9-8A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300, PE251 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: HIV/AIDS | | | |

| |AC |3-2-1C |demonstrate the ability to clean, debride, & protect an open wound |AH101 |PE250, AH300 |AH382 |

| |AC |3-2-1G |demonstrate the ability to apply appropriate dressings |AH102 |PE250, AH300 |AH382 |

Proficiencies

|T.O. |Subj |# |Outcome |Taught |Covered |Eval. |

| |area | | | | | |

| |GM |7-1-9-12C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH300 |

| | | |conditions - Neurological Disorders: reflex sympathetic dystrophy | | | |

| |GM |7-1-9-12D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |AH381 |AH300 |AH300 |

| | | |conditions - Neurological Disorders: meningitis | | | |

| |GM |7-1-9-1I |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH200, AH300 |AH300 |

| | | |conditions: frostbite | | | |

| |GM |7-1-9-1A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: abscesses | | | |

| |GM |7-1-9-1B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: acne vulgaris | | | |

| |GM |7-1-9-1C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: carbuncle | | | |

| |GM |7-1-9-1D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: cellulitis | | | |

| |GM |7-1-9-1E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: molluscum contagiosum | | | |

| |GM |7-1-9-1F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: dermatitis | | | |

| |GM |7-1-9-1G |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: eczema | | | |

| |GM |7-1-9-1H |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: folliculitis | | | |

| |GM |7-1-9-1J |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: furunculosis | | | |

| |GM |7-1-9-1K |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: herpes simplex | | | |

| |GM |7-1-9-1L |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: tinea versicolor | | | |

| |GM |7-1-9-1N |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: pediculosis | | | |

| |GM |7-1-9-1O |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: herpes zoster | | | |

| |GM |7-1-9-1P |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: hives | | | |

| |GM |7-1-9-1Q |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: impetigo | | | |

| |GM |7-1-9-1R |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: psoriasis | | | |

| |GM |7-1-9-1S |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: ringworm | | | |

| |GM |7-1-9-1T |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: scabies | | | |

| |GM |7-1-9-1U |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: sebaceous cysts | | | |

| |GM |7-1-9-1V |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: tinea cruris | | | |

| |GM |7-1-9-1W |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: tinea pedis | | | |

| |GM |7-1-9-1X |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: verruca plantaris | | | |

| |GM |7-1-9-1Y |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: verruca vulgaris | | | |

| |GM |7-1-9-1Z |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY231 |AH300 |AH300 |

| | | |conditions: tinea capitis | | | |

| |GM |7-1-9-13A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions - Systemic Diseases: iron-deficiency anemia | | | |

| |GM |7-1-9-13B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions - Systemic Diseases: sickle cell anemia | | | |

| |GM |7-1-9-13C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions - Systemic Diseases: Lyme disease | | | |

| |GM |7-1-9-9A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: kidney stones | | | |

| |GM |7-1-9-9B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: spermatic cord torsion | | | |

| |GM |7-1-9-9C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: candidiasis | | | |

| |GM |7-1-9-9D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: urethritis | | | |

| |GM |7-1-9-9E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: urinary tract infection | | | |

| |GM |7-1-9-9F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: hydrocele | | | |

| |GM |7-1-9-9G |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300 |AH300 |

| | | |conditions of the Genitourinary Tract & Organs: varicocele | | | |

| |GM |7-1-9-5A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300, PE250 |AH300 |

| | | |conditions of the Endocrine System: diabetes | | | |

| |GM |7-1-9-5B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300, PE250 |AH300 |

| | | |conditions of the Endocrine System: hyperthyroidism | | | |

| |GM |7-1-9-5C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300, PE250 |AH300 |

| | | |conditions of the Endocrine System: hypothyroidism | | | |

| |GM |7-1-9-5D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |BY232 |AH300, PE250 |AH300 |

| | | |conditions of the Endocrine System: pancreatitis | | | |

| |GM |7-1-9-4E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH200, AH300 |AH300 |

| | | |conditions of the Cardiovascular System: shock | | | |

| |GM |7-1-9-4A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: hypertension | | | |

| |GM |7-1-9-4B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: hypertrophic myocardiopathy | | | |

| |GM |7-1-9-4C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: hypotension | | | |

| |GM |7-1-9-4D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: migraine headache | | | |

| |GM |7-1-9-4F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions of the Cardiovascular System: syncope | | | |

| |GM |7-1-9-7B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300 |AH300 |

| | | |conditions associated with Eating Disorders: bulimia | | | |

| |GM |7-1-9-12A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300, PE251 |AH300 |

| | | |conditions - Neurological Disorders: epilepsy | | | |

| |GM |7-1-9-12B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300, PE251 |AH300 |

| | | |conditions - Neurological Disorders: syncope | | | |

| |GM |7-1-9-7A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300, PE251 |AH300 |

| | | |conditions associated with Eating Disorders: anorexia | | | |

| |GM |7-1-9-7C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE250 |AH300, PE251 |AH300 |

| | | |conditions associated with Eating Disorders: obesity | | | |

| |GM |7-1-9-10A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: amenorrhea | | | |

| |GM |7-1-9-10B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: dysmenorrheal | | | |

| |GM |7-1-9-10C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: oligomenorrhea | | | |

| |GM |7-1-9-10D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: pelvic inflammatory disease | | | |

| |GM |7-1-9-10E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Gynecological Disorders: vaginitis | | | |

| |GM |7-1-9-11A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Viral Syndromes: infectious mononucleosis | | | |

| |GM |7-1-9-11B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Viral Syndromes: measles | | | |

| |GM |7-1-9-11C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Viral Syndromes: mumps | | | |

| |GM |7-1-9-8B |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: hepatitis | | | |

| |GM |7-1-9-8C |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: chlamydia | | | |

| |GM |7-1-9-8D |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: genital warts | | | |

| |GM |7-1-9-8E |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: gonorrhea | | | |

| |GM |7-1-9-8F |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: syphilis | | | |

| |NA |8-1-1B |demonstrate the ability to access & recommend nutritional guidelines for weight loss |PE251 |AH300 |AH300 |

| |NA |8-1-1C |demonstrate the ability to access & recommend nutritional guidelines for weight gain |PE251 |AH300 |AH300 |

| |GM |7-1-9-8A |Recognize the signs, symptoms, & predisposing conditions associated with the following diseases & |PE251 |AH300, PE251 |AH300 |

| | | |conditions - Sexually Transmitted Diseases/Diseases Transmitted by Body Fluid: HIV/AIDS | | | |

CALENDER:

Due date for skin disorder project: March 5, 2005

Due date for pharmacology project: March 26, 2005

Students will not attend class on Martin Luther King Day, Assessment Day, or Spring Break

|January 12, 14, 16 |Blood Borne Pathogens (AIDS & HBV), |

|January 21 & 23 |OSHA Regulations, Article 1 due |

|January 26, 28, & 30 |Heart Conditions Article 2 due |

|February 2, 4, & 6 |Eating Disorders, Article 3 due TEST 1 |

|February 9, 11, 13 |Skin disorders, Article 4 due |

|February 16, 18, & 20 |Viral infections & Bacterial infections Eye and Ear Injury and disease, Article 5 due |

|February 23, 25, & 27 |Fungal infections, other illnesses seen in athletics |

|March 1, 3, & 5 |Pharmacology, & skin disorder paper due |

|March 8, 10, & 12 |Drug use and Abuse in Sports |

|March 15, 17, & 19 |Drugs cont., |

|March 22, 24, & 26 |Drugs cont, TEST 2, Drug paper due |

|April 5, 7, & 9 |Gynecological & Urological Irregularities |

|April 12, 14, & 16 |Eye and Ear Injury and disease |

|April 19, 21, & 23 |Upper Respiratory Infections & Anaphylaxis and Asthma Conditions |

|April 26, & 28 |Endocrine, GI Tract, & STD’S., TEST 3 |

|Final Exams |Final Exam |

Articles List: These are to be e-mailed in on the above Friday of the listed week by 11:00am.

1. Current events on AIDS

2. Hypertrophic Cardiac Myopathy

3. Anorexia nervosa

4. Antibiotic Resistant Bacterial Infections

5. Retina detachment

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download